RxDoctor Payments Data

Amy Hird, PA

Family Medicine · Durham, NCNPI 1992874143

Payments from drug & device makers

$1,009in general payments, 2019–2025

Across 50 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$294
  • Lilly USA, LLC$177
  • Bayer$114
  • AbbVie$100
  • Pfizer$58
  • Exact Sciences$52
  • plus $214 from 8 others

What the payments were for

  • Food & beverage$99499%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,009 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$17,120
Medicare patients
51
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$34,160
RybelsusSemaglutide15$26,659
JardianceEmpagliflozin18$24,890
SymbicortBudesonide/Formoterol Fumarate14$3,496
Atorvastatin Calcium138$1,530
Valsartan57$1,376
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide14$1,012
Gabapentin40$872
Levothyroxine Sodium52$835
Propranolol Hcl19$677
Rosuvastatin Calcium62$492
Albuterol Sulfate HfaAlbuterol Sulfate18$490
Celecoxib14$429
Metoprolol Succinate40$425
Simvastatin25$376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$34,16023 claims
Novo NordiskRybelsus$294$26,65915 claims
AstraZenecaSymbicort$15$3,49614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →